Hence, in the present work, we hypothesized that targeting the VEGF signaling in ccRCC via a bifurcated approach by combining Everolimus and EG00229 in a tumor-targeted liposomal formulation will be beneficial. This evidence concerns the gene VEGFA and nonpapillary renal cell carcinoma.